搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 30 天
时间不限
过去 1 小时
过去 24 小时
过去 7 天
按相关度排序
按时间排序
Opinion
10 小时
Opinion
Weight loss drug opportunity is increasingly coming into focus for Indian pharma
Weight loss drugs, which took the US market by storm, are looking to be a big opportunity for drug makers in India. Several ...
11 小时
India’s apex drug adviser’s term expired in October. The govt didn’t know.
India's apex drug advisory body has been inactive since its term ended in October. This was brought to the health ministry's ...
cnbctv18
1 天
Abbott India Q3 Results: Pharma stock surges over 6% on steady earnings growth
Shares of Abbott India surged 5.60% higher at ₹27,605.45 on the BSE on Tuesday. The pharma stock reacted positively to the ...
ThePrint
21 分钟
Global researchers call for robust regulatory framework for e-pharmacies to enhance safety
A research by the George Institute for Global Health, with collaborators from Strathmore Business School in Kenya and the London School of Hygiene and Tropical Medicine, has called for a robust ...
Forbes India
6 天
Why Indian pharma needs to elevate ESG for sustainable future
Indian pharmaceutical companies lag behind global peers in ESG practices, facing regulatory, awareness, and resource ...
21 小时
India’s key drug advisory body ceases to exist, policy decisions on hold: Report
Reconstituting the DTAB is expected to take 2-3 months, as the board requires representation from the industry, as well as ...
9 小时
on MSN
Dividend stocks 2025: Sun Pharma, CCI to IRB infra — six stocks to trade ex-dividend today
Sun Pharma, Container Corporation, IRB Infra, Triveni Turbine, Sharda Cropchem, India Motor Parts are the six shares that may ...
money.rediff
5 天
India Budget 2023: Import Duty Removed on Critical Minerals, Drugs
India's Finance Minister Nirmala Sitharaman announced the removal of import duties on 25 critical minerals, lithium-ion ...
6 天
on MSN
Top Indian drugmaker Sun Pharma's Q3 profit beats estimates on strong local sales
By Kashish Tandon and Rishika Sadam HYDERABAD/BENGALURU (Reuters) -Sun Pharmaceutical, India's largest drugmaker by revenue, ...
3 天
on MSN
Biocon 'welcomes' India's duty exemptions on cancer, chronic disease drugs
Peter Bains, Group CEO of Biocon, talks about India's budget, and the impact of its plans to cut or remove duties on ...
ThePrint
7 天
Central India’s Leading Pharma Manufacturer, Erawat Pharma, Chooses BatchMaster ERP to ...
BatchMaster Software is proud to welcome Erawat Pharma, one of central India’s most prestigious pharmaceutical manufacturers, ...
The Financial Express
23 小时
EXPLAINER: Why critical drugs are expensive despite import duty waiver
The Union Budget 2025 has waived import duty on 36 life-saving drugs and reduced it for six others. While this is expected to ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈